• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

游离脂肪酸受体4通过肠道微生物群调节饮食中的糖偏好。

Free fatty acid receptor 4 modulates dietary sugar preference via the gut microbiota.

作者信息

Zhang Tingting, Wang Wei, Li Jiayu, Ye Xianlong, Wang Zhe, Cui Siyuan, Shen Shiwei, Liang Xinmiao, Chen Yong Q, Zhu Shenglong

机构信息

Wuxi School of Medicine, Jiangnan University, Wuxi, China.

State Key Laboratory of Food Science and Resources, School of Food Science and Technology, Jiangnan University, Wuxi, China.

出版信息

Nat Microbiol. 2025 Feb;10(2):348-361. doi: 10.1038/s41564-024-01902-8. Epub 2025 Jan 13.

DOI:10.1038/s41564-024-01902-8
PMID:39805952
Abstract

Sugar preference is a key contributor to the overconsumption of sugar and the concomitant increase in the incidence of diabetes. However, the exact mechanism of its development remains ambiguous. Here we show that the expression of free fatty acid receptor Ffar4, a receptor for long-chain fatty acids, is decreased in patients and mouse models with diabetes, which is associated with high sugar intake. Deletion of intestinal Ffar4 in mice resulted in reduced gut Bacteroides vulgatus and its metabolite pantothenate, leading to dietary sugar preference. Pantothenate promoted the secretion of GLP-1 which inhibited sugar preference by stimulating hepatic FGF21 release, which in turn regulates energy metabolism. These findings uncover a previously unappreciated role of Ffar4 in negatively regulating sugar preference and suggest B. vulgatus-derived pantothenate as a potential therapeutic target for diabetes.

摘要

糖偏好是导致糖过度消费以及糖尿病发病率随之上升的关键因素。然而,其发展的确切机制仍不明确。在此我们表明,游离脂肪酸受体Ffar4(一种长链脂肪酸受体)在糖尿病患者和小鼠模型中的表达降低,这与高糖摄入有关。在小鼠中敲除肠道Ffar4会导致肠道普通拟杆菌及其代谢产物泛酸盐减少,从而导致对膳食糖的偏好。泛酸盐促进胰高血糖素样肽-1(GLP-1)的分泌,GLP-1通过刺激肝脏成纤维细胞生长因子21(FGF21)释放来抑制糖偏好,而FGF21反过来调节能量代谢。这些发现揭示了Ffar4在负向调节糖偏好方面此前未被认识到的作用,并表明普通拟杆菌衍生的泛酸盐是糖尿病的一个潜在治疗靶点。

相似文献

1
Free fatty acid receptor 4 modulates dietary sugar preference via the gut microbiota.游离脂肪酸受体4通过肠道微生物群调节饮食中的糖偏好。
Nat Microbiol. 2025 Feb;10(2):348-361. doi: 10.1038/s41564-024-01902-8. Epub 2025 Jan 13.
2
Fibroblast growth factor 21 improves insulin sensitivity by modulating the bile acid-gut microbiota axis in type Ⅱ diabetic mice.成纤维细胞生长因子 21 通过调节 2 型糖尿病小鼠的胆汁酸-肠道微生物群轴改善胰岛素敏感性。
Free Radic Biol Med. 2024 Nov 1;224:600-617. doi: 10.1016/j.freeradbiomed.2024.09.017. Epub 2024 Sep 15.
3
Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.肠法尼醇 X 受体激动剂和肠道微生物群激活 G 蛋白胆汁酸受体-1 信号通路以改善代谢。
Hepatology. 2018 Oct;68(4):1574-1588. doi: 10.1002/hep.29857. Epub 2018 May 21.
4
The nuclear receptor FXR inhibits Glucagon-Like Peptide-1 secretion in response to microbiota-derived Short-Chain Fatty Acids.核受体 FXR 可抑制细菌来源的短链脂肪酸对胰高血糖素样肽-1 的分泌。
Sci Rep. 2020 Jan 13;10(1):174. doi: 10.1038/s41598-019-56743-x.
5
Liver-derived fibroblast growth factor 21 mediates effects of glucagon-like peptide-1 in attenuating hepatic glucose output.肝源成纤维细胞生长因子 21 介导胰高血糖素样肽-1 减轻肝葡萄糖输出的作用。
EBioMedicine. 2019 Mar;41:73-84. doi: 10.1016/j.ebiom.2019.02.037. Epub 2019 Mar 1.
6
GLP-1R signaling modulates colonic energy metabolism, goblet cell number and survival in the absence of gut microbiota.GLP-1R 信号转导调节结肠能量代谢、杯状细胞数量和在没有肠道微生物群的情况下的存活。
Mol Metab. 2024 May;83:101924. doi: 10.1016/j.molmet.2024.101924. Epub 2024 Mar 21.
7
Double knockout of FFAR4 and FGF21 aggravates metabolic disorders in mice.双重敲除 FFAR4 和 FGF21 可加重小鼠的代谢紊乱。
Int J Biol Macromol. 2023 Dec 31;253(Pt 1):126553. doi: 10.1016/j.ijbiomac.2023.126553. Epub 2023 Aug 30.
8
Jiang Tang San Hao Formula exerts its anti-diabetic effect by affecting the gut-microbiota-brain axis.姜糖三耗方通过影响肠道微生物群-脑轴发挥其降糖作用。
Phytomedicine. 2024 Dec;135:156100. doi: 10.1016/j.phymed.2024.156100. Epub 2024 Oct 1.
9
Kazak faecal microbiota transplantation induces short-chain fatty acids that promote glucagon-like peptide-1 secretion by regulating gut microbiota in mice.哈萨克粪菌移植通过调节肠道微生物群促进胰高血糖素样肽-1的分泌产生短链脂肪酸。
Pharm Biol. 2021 Dec;59(1):1077-1087. doi: 10.1080/13880209.2021.1954667.
10
Endogenous -3 PUFAs Improve Non-Alcoholic Fatty Liver Disease through FFAR4-Mediated Gut-Liver Crosstalk.内源性 -3PUFAs 通过 FFAR4 介导的肠-肝串扰改善非酒精性脂肪性肝病。
Nutrients. 2023 Jan 22;15(3):586. doi: 10.3390/nu15030586.

引用本文的文献

1
Galacto-Oligosaccharides Exert Bifidogenic Effects at Capsule-Compatible Ultra-Low Doses.低聚半乳糖在与胶囊相容的超低剂量下发挥双歧杆菌增殖作用。
Metabolites. 2025 Aug 5;15(8):530. doi: 10.3390/metabo15080530.
2
Examining gut microbiota and metabolites to clarify mechanisms of Lour leaf components against type 2 diabetes.研究肠道微生物群和代谢物以阐明罗汉果叶成分抗2型糖尿病的机制。
World J Diabetes. 2025 Jul 15;16(7):104512. doi: 10.4239/wjd.v16.i7.104512.
3
A magnetic resonance imaging and gut flora-based study of intake desire in overweight/obese type 2 diabetes mellitus patients.

本文引用的文献

1
Microglial Ffar4 deficiency promotes cognitive impairment in the context of metabolic syndrome.在代谢综合征背景下,小胶质细胞Ffar4缺乏会促进认知障碍。
Sci Adv. 2024 Feb 2;10(5):eadj7813. doi: 10.1126/sciadv.adj7813.
2
Incretins (GLP-1 receptor agonists and dual/triple agonists) and the liver.肠降血糖素(GLP-1 受体激动剂和双重/三重激动剂)与肝脏。
J Hepatol. 2023 Dec;79(6):1557-1565. doi: 10.1016/j.jhep.2023.07.033. Epub 2023 Aug 9.
3
Fibroblast growth factor-21 is required for weight loss induced by the glucagon-like peptide-1 receptor agonist liraglutide in male mice fed high carbohydrate diets.
一项基于磁共振成像和肠道菌群的超重/肥胖2型糖尿病患者进食欲望研究。
Front Neurosci. 2025 Jun 18;19:1612722. doi: 10.3389/fnins.2025.1612722. eCollection 2025.
成纤维细胞生长因子 21 是胰高血糖素样肽-1 受体激动剂利拉鲁肽诱导雄性高糖饮食喂养小鼠体重减轻所必需的。
Mol Metab. 2023 Jun;72:101718. doi: 10.1016/j.molmet.2023.101718. Epub 2023 Apr 7.
4
Dietary sugar consumption and health: umbrella review.饮食糖的摄入与健康:伞式综述。
BMJ. 2023 Apr 5;381:e071609. doi: 10.1136/bmj-2022-071609.
5
Glycoursodeoxycholic acid regulates bile acids level and alters gut microbiota and glycolipid metabolism to attenuate diabetes.甘氨熊脱氧胆酸可调节胆汁酸水平,并改变肠道微生物群和糖脂代谢,从而减轻糖尿病。
Gut Microbes. 2023 Jan-Dec;15(1):2192155. doi: 10.1080/19490976.2023.2192155.
6
Endogenous -3 PUFAs Improve Non-Alcoholic Fatty Liver Disease through FFAR4-Mediated Gut-Liver Crosstalk.内源性 -3PUFAs 通过 FFAR4 介导的肠-肝串扰改善非酒精性脂肪性肝病。
Nutrients. 2023 Jan 22;15(3):586. doi: 10.3390/nu15030586.
7
Pyruvate dehydrogenase B regulates myogenic differentiation via the FoxP1-Arih2 axis.丙酮酸脱氢酶 B 通过 FoxP1-Arih2 轴调节成肌分化。
J Cachexia Sarcopenia Muscle. 2023 Feb;14(1):606-621. doi: 10.1002/jcsm.13166. Epub 2022 Dec 23.
8
Free Fatty Acid Receptors (FFARs): Emerging Therapeutic Targets for the Management of Diabetes Mellitus.游离脂肪酸受体(FFARs):用于治疗糖尿病的新兴治疗靶点。
Curr Med Chem. 2023;30(30):3404-3440. doi: 10.2174/0929867329666220927113614.
9
Excessive intake of sugar: An accomplice of inflammation.过量摄入糖:炎症的帮凶。
Front Immunol. 2022 Aug 31;13:988481. doi: 10.3389/fimmu.2022.988481. eCollection 2022.
10
Gut-brain circuits for fat preference.肠道-大脑脂肪偏好回路。
Nature. 2022 Oct;610(7933):722-730. doi: 10.1038/s41586-022-05266-z. Epub 2022 Sep 7.